or Try an Advanced Search...

    Technical Analysis for ADCT - ADC Therapeutics SA

    Grade Last Price % Change Price Change
    D 4.10 0.24% 0.01
    ADCT closed up 0.24 percent on Friday, May 17, 2024, on 73 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical ADCT trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Oversold Stochastic Weakness 0.24%
    Oversold Stochastic Weakness -0.73%
    Stochastic Reached Oversold Weakness 1.49%
    BB Squeeze Ended Range Expansion 1.49%
    Below Lower BB Weakness 1.49%
    Down 3 Days in a Row Weakness 1.49%
    Lower Bollinger Band Touch Weakness 1.49%
    Oversold Stochastic Weakness 1.49%
    Older End-of-Day Signals for ADCT ...

       Recent Intraday Alerts

    Alert Time
    Down 2 % 3 days ago
    Down 1% 3 days ago
    60 Minute Opening Range Breakout 4 days ago
    Down 3% 4 days ago
    Up 3% 4 days ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ADCT Chart by TradingView
    Basic chart:

    Profile

    ADC Therapeutics SA is a clinical-stage biotechnology company, which develops antibody drug conjugates. Its products include Lonca, Cami and ADCT-602. Its drugs are used in treating various advanced solid tumors. The company was founded on June 6, 2011 and is headquartered in Epalinges, Switzerland.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Clinical Medicine Solid Tumors Drugs Monoclonal Antibodies Advanced Solid Tumors Antibody Drug Conjugate Lonca Synaffix

    Is ADCT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 14 ADC Therapeutics down 7% following new corporate presentation
    May 10 ADC Therapeutics First Quarter 2024 Earnings: In Line With Expectations
    May 9 Insider Sale: CEO Ameet Mallik Sells 29,731 Shares of ADC Therapeutics SA (ADCT)
    May 9 ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference
    May 9 ADC Therapeutics SA (NYSE:ADCT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
    May 1 ADC Therapeutics to Host First Quarter 2024 Financial Results and Pipeline Update Conference Call on May 6, 2024
    Apr 4 ADC Therapeutics gains after data for lymphoma therapy
    Apr 4 ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Glofitamab or Mosunetuzumab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
    Apr 3 ADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9, 2024
    Apr 1 ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
    See more ADCT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 6.04
    52 Week Low 0.3599
    Average Volume 566,743
    200-Day Moving Average 2.45
    50-Day Moving Average 4.49
    20-Day Moving Average 4.48
    10-Day Moving Average 4.31
    Average True Range 0.39
    RSI (14) 42.86
    ADX 15.29
    +DI 15.28
    -DI 24.41
    Chandelier Exit (Long, 3 ATRs) 4.01
    Chandelier Exit (Short, 3 ATRs) 4.96
    Upper Bollinger Bands 5.04
    Lower Bollinger Band 3.92
    Percent B (%b) 0.16
    BandWidth 24.90
    MACD Line -0.12
    MACD Signal Line -0.06
    MACD Histogram -0.0643
    Fundamentals Value
    Market Cap 330.63 Million
    Num Shares 80.6 Million
    EPS -2.18
    Price-to-Earnings (P/E) Ratio -1.88
    Price-to-Sales 2.87
    Price-to-Book 2.58
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.36
    Resistance 3 (R3) 4.36 4.27 4.32
    Resistance 2 (R2) 4.27 4.20 4.27 4.30
    Resistance 1 (R1) 4.18 4.16 4.14 4.19 4.29
    Pivot Point 4.09 4.09 4.07 4.09 4.09
    Support 1 (S1) 4.01 4.02 3.96 4.01 3.91
    Support 2 (S2) 3.92 3.98 3.92 3.90
    Support 3 (S3) 3.83 3.92 3.88
    Support 4 (S4) 3.84